0
0
Read Time:14 Second
Strides Pharma Science Limited has informed the Exchange regarding a press release dated February 05, 2026, titled “Strides Pharma Inc receives USFDA closure report (EIR) for its formulations facility at Chestnut Ridge, New YorkInspection included Drug Device Combinations covering our recent filling in Nasal Sprays domain”. |SUBJECT: Press Release
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %